Besides, the PI3K/AKT/mTOR pathway is considered as a perspective molecular therapeutic target for STS and GIST, accumulating evidence also illustrates the tight connection between this pathway and checkpoint responses and repair of DNA damage, induced by certain chemotherapeutic agents and/or ionizing radiation. This evidence concerns the gene MTOR and gastrointestinal stromal tumor.